首页 | 本学科首页   官方微博 | 高级检索  
检索        

荷叶联用辛伐他汀对糖尿病患者脂质过氧化及血液流变学的影响
引用本文:蔡琴,郭成坤,罗顶世.荷叶联用辛伐他汀对糖尿病患者脂质过氧化及血液流变学的影响[J].中南药学,2014(6):535-537.
作者姓名:蔡琴  郭成坤  罗顶世
作者单位:[1]荆门市第一人民医院药剂科,湖北荆门448000; [2]荆门市第一人民医院肾内科,湖北荆门448000
基金项目:湖北省荆门市科技计划重点项目(编号:2013YD22)
摘    要:目的研究荷叶对糖尿病患者脂质过氧化及血液流变学的影响。方法 120例2型糖尿病患者随机分为治疗组(n=60)及对照组(n=60),治疗组给予口服辛伐他汀20 mg+荷叶9 g煎服(分3次),对照组辛伐他汀20 mg,治疗前及治疗4周后观察2组患者胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL-C)、低密度脂蛋白(LDL-C)、脂质过氧化物(LPO)、超氧化物歧化酶(SOD)及血液流变学相关指标,并比较治疗前后上述指标有无统计学差异。结果治疗组治疗前后TC(6.77±1.30)vs(5.43±1.10)mmol·L-1、TG(1.93±0.81)vs(1.13±0.52)mmol·L-1、HDL-C(1.26±0.60)vs(1.85±0.58)mmol·L-1、LDL-C(3.62±0.80)vs(2.75±0.63)mmol·L-1、LPO(5.90±0.86)vs(4.72±1.36)μmol·L-1、SOD(674±45)vs(998±56)U·L-1比较差异有统计学意义(P<0.05),对照组治疗前后TC(6.75±1.60)vs(5.52±1.71)mmol·L-1、TG(1.90±1.13)vs(1.35±1.14)mmol·L-1、HDL-C(1.24±0.91)vs(1.72±0.66)mmol·L-1、LDL-C(3.82±1.07)vs(2.97±1.01)mmol·L-1、LPO(5.94±2.15)vs(5.82±1.55)μmol·L-1、SOD(698±54)vs(703±64)U·L-1,差异有统计学意义(P<0.05),治疗后治疗组血液流变学与对照组比较(6.78±1.85)vs(7.32±1.86)mPas,差异有统计学意义(P<0.05)。治疗后2组组间上述指标比较有统计学差异(P<0.05)。结论荷叶除降低糖尿病患者血脂作用外,还可显著改善糖尿病患者体内氧化应激状态以及血液流变学,可作为治疗糖尿病患者辅助手段,在临床推广应用。

关 键 词:荷叶  辛伐他汀  糖尿病  脂质过氧化  血液流变学

Effect of lotus leaf combined with simvastatin on lipid peroxidation and hemorheology in diabetics patients
Institution:CAI Qin, GUO Cheng-kun, LUO Ding-shi (1. Pharmaceutical Department of the First People's Hospital of Jingmen, Jingmen Hubei 448000; 2. Nephrology Department of the First People's Hospital of Jingmen, Jing- men Hubei 448000)
Abstract:Objective To investigate the effect of lotus leaf combined with simvastatin on diabetic lipid peroxidation and hemorheology. Methods Totally 120 cases of type 2 diabetic patients were randomly divided into a treatment group(n = 60) and a control group(n = 60). The treatment group received oral simvastatin 20 mg + lotus leaf granules 9 g, 3 times a day. The control group were given simvastatin 20 mg. Before the treatment and 4 weeks after both groups were observed such indictors as cholesterol(TC), triglyceride(TG), high density lipoprotein(HDL-C), low density lipoprotein(LDL-C), lipid peroxide(LPO), superoxide dismutase(SOD) and hemorheology. Results Before the treatment and after the treatment, TC was(6.77±1.30) vs(5.43±1.10) mmol ·L-1, TG was(1.93±0.81) vs(1.13±0.52) mmol·L-1, HDL-C was(1.26±0.60) vs(1.85±0.58) mmol·L-1, LDL-C was(3.62±0.80) vs(2.75±0.63) mmol·L-1, LPO(5.90±0.86) vs(4.72±1.36) μmol·L-1, and SOD(674±45) vs(998±56) U·L-1 in the treatment group, with significant difference(P 0.05). In the control group, before the treatment and after the treatment, TC was(6.75±1.60) vs(5.52±1.71) mmol·L-1, TG was(1.90±1.13) vs(1.35±1.14) mmol·L-1, HDLC was(1.24±0.91) vs(1.72±0.66) mmol·L-1, LDL-C was(3.82±1.07) vs(2.97±1.01) mmol·L-1, LPO was(5.94±2.15) vs(5.82±1.55) μmol·L-1, and SOD was(698±54) vs(703±64) U·L-1 with significant difference(P 0.05). the treatment group hemorheology compared with the control group(6.78±1.85) vs(7.32±1.86) mPas were significantly different(P0.05). After treatment difference were significant between 2 groups(P0.05). Conclusion In addition to lowering blood lipids in patients with diabetes, lotus leaf also significantly improves the state of oxidative stress in patients with diabetes and blood hemorheology, so it can be used as an adjunct for the treatment of diabetic patients.
Keywords:lotus leaf  simvastatin  diabetes  lipid peroxidation  hemorheology
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号